Literature DB >> 11085836

The utility of resistance exercise training and amino acid supplementation for reversing age-associated decrements in muscle protein mass and function.

G Parise1, K E Yarasheski.   

Abstract

Advancing age is associated with reduced skeletal muscle protein synthesis, altered expression of and chemical modifications to muscle proteins, reduced muscle strength, muscle strength per unit muscle mass and muscle power (sarcopenia). These age-associated impairments in the quantity and quality of contractile protein contribute to physical disability and frailty, a loss of independent function, the risk of falling and fractures, and escalating health-care costs. Progressive resistance exercise training is a potent, non-pharmacologic, efficacious therapy for the impairment in muscle quantity and quality in middle age and physically frail adults. Evidence is accumulating that dietary amino acid supplementation may also improve muscle protein balance in the elderly. Several potential cellular mechanisms for the loss of muscle protein and resistance exercise-induced improvements in muscle quantity and quality in elderly adults are reviewed.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11085836     DOI: 10.1097/00075197-200011000-00012

Source DB:  PubMed          Journal:  Curr Opin Clin Nutr Metab Care        ISSN: 1363-1950            Impact factor:   4.294


  8 in total

1.  2,000 Steps/Day Does Not Fully Protect Skeletal Muscle Health in Older Adults During Bed Rest.

Authors:  Emily Arentson-Lantz; Elfego Galvan; Adam Wacher; Christopher S Fry; Douglas Paddon-Jones
Journal:  J Aging Phys Act       Date:  2019-01-20       Impact factor: 1.961

Review 2.  Emerging molecular mediators and targets for age-related skeletal muscle atrophy.

Authors:  Lemuel A Brown; Steve D Guzman; Susan V Brooks
Journal:  Transl Res       Date:  2020-03-10       Impact factor: 7.012

3.  A phase IIA randomized, placebo-controlled clinical trial to study the efficacy and safety of the selective androgen receptor modulator (SARM), MK-0773 in female participants with sarcopenia.

Authors:  D A Papanicolaou; S N Ather; H Zhu; Y Zhou; J Lutkiewicz; B B Scott; J Chandler
Journal:  J Nutr Health Aging       Date:  2013       Impact factor: 4.075

4.  A validation of the application of D(2)O stable isotope tracer techniques for monitoring day-to-day changes in muscle protein subfraction synthesis in humans.

Authors:  Daniel J Wilkinson; Martino V Franchi; Matthew S Brook; Marco V Narici; John P Williams; William K Mitchell; Nathaniel J Szewczyk; Paul L Greenhaff; Philip J Atherton; Kenneth Smith
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-12-31       Impact factor: 4.310

Review 5.  Skeletal muscle homeostasis and plasticity in youth and ageing: impact of nutrition and exercise.

Authors:  M S Brook; D J Wilkinson; B E Phillips; J Perez-Schindler; A Philp; K Smith; P J Atherton
Journal:  Acta Physiol (Oxf)       Date:  2015-06-21       Impact factor: 6.311

Review 6.  Radiologically Determined Sarcopenia Predicts Morbidity and Mortality Following Abdominal Surgery: A Systematic Review and Meta-Analysis.

Authors:  Keaton Jones; Alex Gordon-Weeks; Claire Coleman; Michael Silva
Journal:  World J Surg       Date:  2017-09       Impact factor: 3.352

7.  Effects of leucine-enriched essential amino acid and whey protein bolus dosing upon skeletal muscle protein synthesis at rest and after exercise in older women.

Authors:  Daniel J Wilkinson; Syed S I Bukhari; Bethan E Phillips; Marie C Limb; Jessica Cegielski; Matthew S Brook; Debbie Rankin; William K Mitchell; Hisamine Kobayashi; John P Williams; Jonathan Lund; Paul L Greenhaff; Kenneth Smith; Philip J Atherton
Journal:  Clin Nutr       Date:  2017-09-23       Impact factor: 7.324

8.  Premature aging in skeletal muscle lacking serum response factor.

Authors:  Charlotte Lahoute; Athanassia Sotiropoulos; Marilyne Favier; Isabelle Guillet-Deniau; Claude Charvet; Arnaud Ferry; Gillian Butler-Browne; Daniel Metzger; David Tuil; Dominique Daegelen
Journal:  PLoS One       Date:  2008-12-11       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.